WorldCat Identities

Reid, Tony

Overview
Works: 17 works in 31 publications in 1 language and 98 library holdings
Genres: Biography  Personal narratives  Directories  History  Guidebooks 
Roles: Author, Performer
Classifications: UB342, 338.914
Publication Timeline
.
Most widely held works by Tony Reid
Legal industrial espionage : a sourcebook and guide to finding company information( Book )

7 editions published between 1900 and 1985 in English and Undetermined and held by 35 WorldCat member libraries worldwide

MATARAM : a novel of love, faith and power in early java by Tony Reid( )

2 editions published in 2018 in English and held by 15 WorldCat member libraries worldwide

Seventeenth-century Java is in turmoil between its Hindu-Buddhist past and its Muslim future, while pepper draws Europe's quarrelling spice-hungry traders to its shores. Thomas Hodges of the East India Company seizes a chance at glory by being the first to venture ashore at the pepper port of Banten in 1608. Will he unlock the mysterious riches of Java for the English, or die forgotten with a Javanese kris or Portuguese poignard between his ribs? He falls under the spell of a captivating interpreter, Sri, but can only retain both her and his Englishness by inventing a mission from King James t
Guide to European Community grants and loans : for commerce, industry, local authorities, academic and research institutions by Tony Reid( Book )

6 editions published between 1990 and 1992 in English and held by 13 WorldCat member libraries worldwide

Money for research and development, 1986-87 by Gay Scott( Book )

1 edition published in 1986 in English and held by 8 WorldCat member libraries worldwide

Bohemian A.F.C. : official club history, 1890-1976 by Tony Reid( Book )

2 editions published between 1976 and 1977 in English and held by 7 WorldCat member libraries worldwide

A guide to European Community grants and loans : for commerce, industry, local authorities, academic and research institutions by Gay Scott( Book )

1 edition published in 1989 in English and held by 6 WorldCat member libraries worldwide

The selfish team by Tony Reid( Book )

1 edition published in 2003 in English and held by 3 WorldCat member libraries worldwide

Towards creative teaching : the life and career of Laura Zirbes, 1884-1967 by Tony Reid( )

2 editions published in 1993 in English and held by 2 WorldCat member libraries worldwide

Guide to European Community Grants and Loans,1991 : For Commerce, industry, local Authorities, academic and Research Institutions (U.K. Edition)( Book )

1 edition published in 1991 in English and held by 2 WorldCat member libraries worldwide

Field trip to outcrops of the eastern San Joaquin basin( Book )

1 edition published in 1998 in English and held by 2 WorldCat member libraries worldwide

Eightsome reel. [and] Eightsome reel( Recording )

1 edition published in 1931 and held by 1 WorldCat member library worldwide

Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study( )

1 edition published in 2015 in English and held by 1 WorldCat member library worldwide

Background Epigenetic alterations have been strongly associated with tumour formation and resistance to chemotherapeutic drugs, and epigenetic modifications are an attractive target in cancer research. RRx-001 is activated by hypoxia and induces the generation of reactive oxygen and nitrogen species that can epigenetically modulate DNA methylation, histone deacetylation, and lysine demethylation. The aim of this phase 1 study was to assess the safety, tolerability, and pharmacokinetics of RRx-001. Methods In this open-label, dose-escalation, phase 1 study, we recruited adult patients (aged >18 years) with histologically or cytologically confirmed diagnosis of advanced, malignant, incurable solid tumours from University of California at San Diego, CA, USA, and Sarah Cannon Research Institute, Nashville, TN, USA. Key eligibility criteria included evaluable disease, Eastern Cooperative Group performance status of 2 or less, an estimated life expectancy of at least 12 weeks, adequate laboratory parameters, discontinuation of all previous antineoplastic therapies at least 6 weeks before intervention, and no residual side-effects from previous therapies. Patients were assigned to receive intravenous infusions of RRx-001 at increasing doses (10 mg/m2, 16·7 mg/m2, 24·6 mg/m2, 33 mg/m2, 55 mg/m2, and 83 mg/m2) either once or twice-weekly for at least 4 weeks, with at least three patients per dose cohort and allowing a 2-week observation period before dose escalation. Samples for safety and pharmacokinetics analysis, including standard chemistry and haematological panels, were taken on each treatment day. The primary objective was to assess safety, tolerability, and dose-limiting toxic effects of RRx-001, to determine single-dose pharmacokinetics, and to identify a recommended dose for phase 2 trials. All analyses were done per protocol. Accrual is complete and follow-up is still on-going. This trial is registered with ClinicalTrials.gov, number NCT01359982. Findings Between Oct 10, 2011, and March 18, 2013, we enrolled 25 patients and treated six patients in the 10 mg/m2 cohort, three patients in the 16·7 mg/m2 cohort, three patients in the 24·6 mg/m2 cohort, four patients in the 33 mg/m2 cohort, three patients in the 55 mg/m2, and six patients in the 83 mg/m2 cohort. Pain at the injection site, mostly grade 1 and grade 2, was the most common adverse event related to treatment, experienced by 21 (84%) patients. Other common drug-related adverse events included arm swelling or oedema (eight [32%] patients), and vein hardening (seven [28%] patients). No dose-limiting toxicities were observed. Time constraints related to management of infusion pain from RRx-001 resulted in a maximally feasible dose of 83 mg/m2. Of the 21 evaluable patients, one (5%) patient had a partial response, 14 (67%) patients had stable disease, and six (29%) patients had progressive disease; all responses were across a variety of tumour types. Four patients who had received RRx-001 were subsequently rechallenged with a treatment that they had become refractory to; all four responded to the rechallenge. Interpretation RRx-001 is a well-tolerated novel compound without clinically significant toxic effects at the tested doses. Preliminary evidence of activity is promising and, on the basis of all findings, a dose of 16·7 mg/m2 was recommended as the targeted dose for phase 2 trials. Funding EpicentRx (formerly RadioRx)
Till human voices wake us by Ian Hamilton( Book )

1 edition published in 1984 in English and held by 1 WorldCat member library worldwide

An account of a conscientious objector's experiences during World War II
Thank you my dear by Tony Reid( )

1 edition published in 1949 in English and held by 1 WorldCat member library worldwide

Autumn somewhere by Subjazz Proxy (Musical group)( Recording )

1 edition published in 1997 and held by 1 WorldCat member library worldwide

EC Funding For Central And Eastern Europe( )

1 edition published in 1992 in English and held by 0 WorldCat member libraries worldwide

A brief summary of EC financial support to Central and Eastern Europe covering the objectives of nine programmes: PHARE; JOPP; Loans and credit guarantees to the former Soviet Union; TACIS; EBRD; EIB; TEMPUS; ACE; Co-operation in science and technology.--SCAD summary
Ring dynamics in a diesel engine and its effect on oil consumption and blowby by Richard Truscott( Book )

1 edition published in 1983 in English and held by 0 WorldCat member libraries worldwide

 
moreShow More Titles
fewerShow Fewer Titles
Audience Level
0
Audience Level
1
  Kids General Special  
Audience level: 0.73 (from 0.23 for Field trip ... to 1.00 for EC Funding ...)

Languages
English (28)